Murugan Amar
SEC CIK 1809916 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | SVP, GC, Sec | 26.9K | — | $223.5K | 16 | 2021-08-17 | 2024-08-16 |
Most active insiders at ATRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 10% | $4.74M | — |
| 2 | Panacea Innovation Ltd | 10% | — | $3.17M |
| 3 | Cherry Brian N | Dir | $1000.0K | — |
| 4 | Huang James | Dir, 10% | — | $489.0K |
| 5 | Nguyen AnhCo | Pres, CEO, Dir | — | $142.4K |
| 6 | Grant-Huerta Yanina | CAO | — | $56.5K |
| 7 | Ciongoli Gregory Austin | Dir, 10%, See Remarks | — | — |
| 8 | Redmile Group, LLC | Dir | — | — |
| 9 | Fust Matthew K | Dir | — | — |
| 10 | HEIDEN WILLIAM K | Dir | — | — |
Murugan Amar made no open-market trades at ATRA in the last 12 months.
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-20 | 2024-08-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | S - Sale | $6.63 | -1,158 | 26.9K | -4% | -$7,678 |
| 2024-05-20 | 2024-05-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | S - Sale | $0.62 | -32.4K | 695.1K | -4% | -$20.1K | |
| 2024-03-06 | 2024-03-04 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | S - Sale | $0.72 | -10.0K | 727.5K | -1% | -$7,232 | |
| 2024-01-09 | 2024-01-08 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | A - Grant | $0.00 | +475.0K | 737.6K | +181% | $0 | |
| 2023-11-20 | 2023-11-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | S - Sale | $0.39 | -8,307 | 257.1K | -3% | -$3,240 | |
| M | 2023-08-18 | 2023-08-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | S - Sale | $1.65 | -8,672 | 265.4K | -3% | -$14.3K |
| M | 2023-05-18 | 2023-05-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | EVP, CLO | S - Sale | $2.04 | -8,389 | 271.9K | -3% | -$17.1K |
| 2023-03-06 | 2023-03-02 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $3.63 | -4,221 | 279.3K | -1% | -$15.3K | |
| D | 2023-03-03 | 2023-03-01 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | A - Grant | $0.00 | +155.4K | 283.6K | +121% | $0 |
| 2022-11-18 | 2022-11-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $4.49 | -3,612 | 127.6K | -3% | -$16.2K | |
| M | 2022-08-18 | 2022-08-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $5.04 | -3,430 | 131.2K | -3% | -$17.3K |
| M | 2022-05-19 | 2022-05-17 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $5.32 | -3,223 | 133.7K | -2% | -$17.1K |
| D | 2022-03-03 | 2022-03-01 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | A - Grant | $0.00 | +51.8K | 139.5K | +59% | $0 |
| DM | 2022-03-03 | 2022-03-01 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $9.86 | -2,577 | 137.0K | -2% | -$25.4K |
| 2021-11-18 | 2021-11-16 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $17.12 | -2,124 | 87.5K | -2% | -$36.4K | |
| 2021-08-19 | 2021-08-17 | ATRA | Atara Biotherapeutics, Inc. | Murugan Amar | SVP, GC, Sec | S - Sale | $12.53 | -2,080 | 89.7K | -2% | -$26.1K |
Purchase Sale Sale after option exercise All abbreviations